Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myelogenous Leukemia
Ovarian Cancer
Colorectal Cancer
Triple-negative Breast Cancer
Small-cell Lung Cancer

Interventions

BIOLOGICAL: galinpepimut-S
BIOLOGICAL: pembrolizumab
OTHER: Montanide
BIOLOGICAL: GM-CSF

Sponsor

Sellas Life Sciences Group

Collaborators

[object Object]
[object Object]